Welcome to our dedicated page for Oracle news (Ticker: ORCL), a resource for investors and traders seeking the latest updates and insights on Oracle stock.
Oracle Corp. reports developments across enterprise database software, cloud infrastructure, and cloud applications for large organizations. News commonly covers Oracle Cloud Infrastructure, Oracle AI Database services, multicloud database integrations, Fusion Cloud applications, NetSuite, and AI features embedded in supply chain, financial services, construction, and healthcare products.
Company updates also address logistics offerings such as Oracle Fusion Cloud Warehouse Management and Oracle Fusion Cloud Transportation Management, Oracle Health interoperability initiatives, data center infrastructure projects, partner integrations, product recognition, and operating and financial results.
Oracle (ORCL) and Surescripts plan to offer automated prior authorization within Oracle Health workflows, with general availability planned for 2027. Surescripts Prior Authorization Automation retrieves clinical information from a patient’s electronic health record and sends it to the pharmacy benefit manager. For available medications, approvals take a median of 18 seconds when all criteria are met.
If the submitted information does not support an approval, the prescriber is prompted to complete a prior authorization request. Oracle and Surescripts will also explore adding First-Fill Abandonment to Oracle Health workflows to flag prescriptions that patients do not pick up.
Oracle (ORCL) and ID.me announced a collaboration on September 24, 2026, to integrate digital identity tools into Oracle Health solutions.
Organizations using the solution can enable patients to verify their identity before or during check-in and choose which records to share. ID.me's credentialing for electronic prescriptions of controlled substances is already available to Oracle Health customers and is used by more than 100,000 prescribers nationwide.
Oracle (ORCL) was named a Leader in IDC MarketScape's Worldwide Trade Finance Systems 2026 Vendor Assessment, published in August 2026. The assessment evaluated 12 vendors that provide trade finance solutions for corporate banks. IDC MarketScape cited five documented AI agents operating across trade finance tasks, including letter-of-credit workability and guarantee validation.
Oracle's trade finance suite is used by more than 170 banks in over 70 countries. Its SWIFT-certified, cloud-based platform supports digital self-service, process management and back-office operations across trade instruments and supply chain finance.
Oracle (ORCL) announced an expansion of Digital Assets Data Nexus on September 23, 2026, to connect bank payments with digital money.
The planned capabilities include ISO 20022 payment-system integration, a prebuilt link to Oracle Banking Payments, and support for coordinating transactions with Swift Ledger. Configurable wallet and smart-contract controls are intended to apply banks’ policies during execution. Oracle AI Database integration is designed to bring transaction and ledger records together for monitoring, reconciliation, and analysis. Digital Assets Data Nexus is planned to be available in fiscal year 2027; the timing and delivery of described features may change.
Oracle (ORCL) announced its planned Oracle Health Oncology EHR on September 23, 2026 at the Oracle Health and Life Sciences Summit in Orlando. The oncology-specific, AI-powered system is designed to support cancer care from diagnosis through treatment and follow-up by unifying fragmented patient information and workflows.
The context-aware EHR is expected to embed AI agents and clinical decision support to help oncologists and care teams coordinate rapidly changing treatment plans across inpatient and outpatient settings. Planned capabilities include unified cancer-care timelines, connected worklists for nurse navigators, intelligent precision oncology insights that bring together genomic and other clinical data, and streamlined chemotherapy and immunotherapy regimen planning workflows.
Oracle (ORCL) announced new AI capabilities for its Oracle Health revenue cycle management portfolio, planned for release in the coming months to help U.S. healthcare organizations address reimbursement issues earlier in the patient and payment journey.
The AI is being embedded across scheduling, financial clearance, clinical documentation, charge capture, billing, and payment to identify risks, streamline routine tasks, and connect clinical, financial, payer, and operational data. New capabilities include AI-assisted prior authorization, clinical document quality integrity, charge capture and integrity, medical coding for professional fees, and appeal management. Oracle Health also plans to link these reimbursement workflows with enterprise financial operations using Oracle Fusion Cloud Applications.
Oracle (ORCL) and the Buck Institute for Research on Aging are collaborating to use Oracle Life Sciences Data Intelligence to advance research on age-related diseases.
The Buck Institute will analyze more than 122 million de-identified longitudinal Oracle Health Real-World Data records to identify biomarkers that could enable early detection and targeted interventions for aging-related complications. The work supports the Stanford-led THRIVE consortium within ARPA-H’s PROSPR program and aims to help develop a validated FDA-grade “Intrinsic Capacity Score” to measure physical and mental capacity, predict long-term health trajectories, and accelerate aging-related clinical trials.
Oracle (ORCL) introduced enhanced Oracle Life Sciences Data Intelligence on September 23, 2026, combining real-world data, domain-trained AI, and advanced analytics in a single cloud-native platform to accelerate pharmaceutical research and commercialization.
Researchers can use natural language to define and refine patient cohorts, conduct outcome analyses, and automate multistep workflows on a data foundation that includes more than 122 million de-identified longitudinal patient records from Oracle Health Real-World Data. The platform supports secure integration of customer, third-party, and Oracle Health data with enhanced governance to transform patient-level data into decision-ready intelligence.
Specialized AI guides common life sciences tasks such as cohort discovery, clinical trial recruitment, site optimization, health economics and outcomes research, market access research, and evidence generation. Connected intelligence workflows link models, cohorts, and insights, and the system interoperates with OCI, Oracle Life Sciences, Oracle Fusion Cloud applications, and Oracle Health solutions.
Oracle (ORCL) announced that Co-op Live, the UK’s largest arena by capacity, is using Oracle Simphony Cloud Point of Sale and Oracle NetSuite to connect its food and beverage operations with financial management.
The venue aims to optimise inventory, simplify business processes, and support growth by unifying ordering, payments, and operational data across bars, concessions, premium spaces, and self-service kiosks with financial reconciliation, budgeting, and forecasting in NetSuite. This integrated setup is intended to give Co-op Live’s finance and operations teams a shared, real-time view of performance and help them respond more quickly to changing event demand while maintaining fast, reliable service for thousands of guests per show.
Oracle (ORCL) has been named a Leader in the IDC MarketScape: Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment.
The assessment cites Oracle's more than 40 years of delivering real-world data and evidence solutions, including aggregation of EHR data for nearly two decades and an RWD platform launched after the 2022 Cerner acquisition. Oracle also introduced a next-generation AI-powered life sciences platform in 2026 and reports working with every major pharma. Its Life Sciences Data Intelligence integrates customer data with more than 122 million de-identified patient records from over 255 health systems, supported by AI agents for tasks such as cohort identification and regulatory submission support.